Steven Du | Senior director, Pharmacovigilance and pharmacoepidemiology
AMAG Pharmaceuticals

Steven has over 10 years of clinical research and global pharmacovigilance and pharmacoepidemiology experience. He’s currently Senior Director of Pharmacoviglance and Pharmacoepidemiology at AMAG Pharmaceuticals, overseeing all aspects of pre and post-marketing global drug safety and risk management. Prior to joining AMAG, Steven was Associate Director and Head of Pharmacovigilance at KV Pharmaceuticals in St. Louis. Steven also worked at Valeant Pharmaceuticals International in Los Angeles as Medical Officer, Pharmacovigilance and University of Southern California as Epidemiologist. He is Editorial Board member of European Journal of Cancer Care and Life member of Association of International Union Against Cancers Fellows. Steven earned his M.D. at Beijing Medical University, PhD in epidemiology at National University of Singapore and MBA at University of Southern California.